Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat

Acta Physiologica Scandinavica

Volumn 179, Issue 4, 2003, Pages 353-360

  Ye, V Z C ^a   Hodge, G ^a   Yong, J L C ^a   Duggan, K A ^a,b  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

Author keywords

Myocardial fibrosis; Nitric oxide synthase inhibition; Vasoactive intestinal peptide

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TISSUE LEVEL;

ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FIBROSIS; HEART; MALE; METABOLIC CLEARANCE RATE; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; ORGAN SIZE; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, WISTAR; SODIUM, DIETARY; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0346249752     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0001-6772.2003.01200.x     Document Type: Article

References (20)

1. Brilla, C.G. & Weber, K.T. 1992. Reactive and reparative myocardial fibrosis in arterial hypertension. Cardiovasc Res 26, 671-677.
2. Brodde, O.E., Hilleman, S., Kunde, K., Vogebang, M. & Zerkowski, H.R. 1992. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure. J Heart Lung Transplant 11, S164-S174.
3. Campbell, S.E. & Katwa, L.C. 1997. Angiotensin II stimulated expression of transforming growth factor-beta 1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 29, 1947-1958.
4. Conrad, C.H., Brooks, W.W., Hayes, J.A., Sen, S., Robinson, K.G. & Bing, O.H. 1995. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneous hypertensive rat. Circulation 91, 161-170.
5. Davis, R.E., Shelley, S., Macdonald, G.J. & Duggan, K.A. 1992. The effects of a high sodium diet on the metabolism and secretion of vasoactive intestinal peptide in the rabbit. J Physiol 451, 17-23.
6. Duggan, K.A., Hawley, C.M., Macdonald, G.J. & Shelley, S. 1989. Sodium depletion decreases VIP metabolism in the rabbit. J Physiol 418, 252-259.
7. Duggan, K.A., Ye, V.Z.C., Jones, D.M., Davis, R.E. & Macdonald, G.J. 1994. Effect of Endopeptidase 24:11 blockade on plasma and tissue concentrations of vasoactive intestinal peptide. Clin Sci 89, 267-271.
8. Frohlich, E.D., Chien, Y., Sesako, S. & Pegram, B.L. 1993. Relationship between dietary sodium intake, haemodynamics and cardiac mass in SHR and WKY rats. Am J Physiol 264, R30-R34.
9. Kannel, W.B., Levy, D. & Cupples, L.A. 1987. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham study. J Cardiovasc Pharmacol 10, S135-S140.
10. Numaguchi, K., Egoshira, K., Tabemoto, M. et al. 1995. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodelling in rats. Hypertension 26, 957-962.
11. Pechanova, O., Bertanova, I., Pelouch, V. & Babal, P. 1999. L-NAME-induced protein remodelling and fibrosis in the rat heart. Physiol Res 48, 353-362.
12. Sun, W., Tadmori, I., Yang, L., Delgado, M. & Ganea, D. 2000. Vasoactive intestinal peptide (VIP) inhibits TGF-beta 1 production in murine macrophages. J Neuroimmunol 107, 88-99.
13. Tait, J.F., Little, B., Tait, S.A.S. & Flood, C. 1962. The metabolic clearance rate of aldosterone in pregnant and non-pregnant subjects estimated by both single injection and constant-infusion methods. J Clin Invest 41, 2093-2100.
14. Unverferth, D.V., O'Dorisio, T.M., Miller, M.M. et al. 1986. Human and canine ventricular vasoactive intestinal polypeptide: decrease with heart failure. J Lab Clin Med 108, 11-16.
15. Vaskonen, T., Mervaala, E., Krogerus, L. et al. 1997. Cardiovascular effects of chronic inhibition of nitric oxide synthesis and dietary salt in spontaneously hypertensive rats. Hypertens Res 20, 183-192.
16. Williams, B. 2001. Angiotensin II and the pathophysiology of cardiovascular remodelling. Am J Cardiol 87, 10C-17C.
17. Ye, V.Z.C. & Duggan, K.A. 2000. Vasoactive intestinal peptide downregulates the intrahepatic renin-angiotensin system in the rat. Clin Sci 99, 201-206.
18. Ye, V.Z.C., Hodge, G., Yong, J.L.C. & Duggan, K.A. 2002. Early myocardial fibrosis is associated with depletion of vasoactive intestinal peptide in rat heart. J Exp Physiol 87, 539-546.
19. Yu, H.C., Burrell, L.M., Black, M.J. et al. 1998. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 98, 2621-2628.
20. Yuan, B.X. & Leenen, F.H. 1991. Dietary sodium intake and left ventricular hypertrophy in normotensive rats. Am J Physiol 261, H1397-H1401.